Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B

Digestive Diseases and Sciences
M OmataM Ohto

Abstract

We have treated 17 patients with non-A, non-B chronic hepatitis by recombinant interferon alpha (0.3-9 megaunits for 4-28 weeks). In six patients, serum aminotransferase levels fell to normal or near-normal range during treatment. The mean levels of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in 17 patients fell from 156 +/- 80 (mean +/- SD) and 213 +/- 135 at the beginning of treatment to 94 +/- 49 and 112 +/- 71, respectively, at the end of treatment. In 12 patients, liver biopsies were performed before and after (or during) the treatment, and histological activity indices (HAI) were blindly examined by two independent observers. For comparison, we examined histological changes of pre- and posttreatment liver biopsies of 19 patients who were treated by recombinant interferon for chronic hepatitis B. Mean HAI scores improved from 10.0 to 5.4 after treatment in non-A, non-B chronic hepatitis. The most marked reduction was noted in scores of portal inflammation and hepatocellular degeneration and/or necrosis. No such reduction was observed in B-viral chronic hepatitis. These data indicated that rapid biochemical resolution by the treatment was related to histological improvement of the liver in our ...Continue Reading

References

Jul 1, 1979·Annals of Internal Medicine·M BermanE A Jones
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Nov 6, 1986·The New England Journal of Medicine·O YokosukaK Okuda
Sep 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·O YokosukaJ Summers
Sep 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R G KnodellJ Wollman

❮ Previous
Next ❯

Citations

Jan 1, 1994·Cancer Chemotherapy and Pharmacology·M Omata, S Takano
May 1, 1993·Gastroenterologia Japonica·O YokosukaM Omata
Aug 8, 1995·Biochemical Pharmacology·M G Moreno, P Muriel
Jul 1, 1991·Journal of Gastroenterology and Hepatology·K Kiyosawa, S Furuta
Jun 1, 1990·Journal of Clinical Pathology·J C Underwood
Dec 9, 1997·Journal of Clinical Pathology·R BoldoriniG Costanzi
Dec 1, 1990·Postgraduate Medical Journal·M R Jacyna, H C Thomas
Sep 17, 2002·The American Journal of Chinese Medicine·Mosaburo KainumaKatsutoshi Terasawa
Jun 1, 1994·Journal of Gastroenterology·Y AraseM Kobayashi
Feb 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F Sáez-RoyuelaV Carreño
Jul 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·X M LiE R Schiff
Dec 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N ManabeJ A Grimaud
Feb 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A KasaharaY Kishida
Feb 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Leonard B Seeff
Aug 23, 2019·The Cochrane Database of Systematic Reviews·De Zhao KongJian Ping Liu
Jul 1, 1991·Gastroenterologia Japonica·Y KarinoJ Toyota
Sep 1, 1993·American Journal of Hematology·L M Aledort
Jul 1, 1991·Gastroenterologia Japonica·M OmataM Ohto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.